KYOTO -- Japan's Shimadzu has started selling a PCR testing reagent to detect the coronavirus's highly contagious delta variant, which has driven a resurgence in COVID-19 cases around the world.
The company plans to produce enough for 10,000 tests a month. The reagent is for research use only and will not be covered by insurance. It detects the L452R mutation found in delta, which was first reported in India.
re.jpg?width=700&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=394)
